10x Genomics Total Long-Term Assets 2018-2024 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total long-term assets from 2018 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics total long-term assets from 2018 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.7B
Tempus AI (TEM)	$8B
Hims & Hers Health (HIMS)	$7B
Inspire Medical Systems (INSP)	$5.7B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.7B
Azenta (AZTA)	$2.4B
Clover Health Investments (CLOV)	$2.2B
Omnicell (OMCL)	$2.1B
Schrodinger (SDGR)	$1.8B
Phreesia (PHR)	$1.7B
Butterfly Network (BFLY)	$748M
Standard BioTools (LAB)	$588M
Talkspace (TALK)	$537M
Fulgent Genetics (FLGT)	$515M
TruBridge (TBRG)	$362M
Nyxoah SA (NYXH)	$354M
Health Catalyst (HCAT)	$343M
SOPHiA GENETICS SA (SOPH)	$235M
Pulmonx (LUNG)	$230M
American Well (AMWL)	$169M
EUDA Health Holdings (EUDA)	$96M
P3 Health Partners (PIII)	$69M
CareCloud (CCLD)	$58M
HeartBeam (BEAT)	$58M
111 (YI)	$47M
Outset Medical (OM)	$44M
Zepp Health (ZEPP)	$42M
SHL Telemedicine (SHLT)	$42M